Ingrid Delaet Neurocrine Biosciences Inc (NBIX) insider trading activity

Ingrid Delaet is Chief Regulatory Officer of NEUROCRINE BIOSCIENCES INC. Currently has a direct ownership of 4,730 shares of NBIX, which is worth approximately $561,545. The most recent transaction as insider was on Feb 13, 2025, when has been sold 1,471 shares (Common Stock) at a price of $116.71 per share, resulting in proceeds of $171,680. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.73K

88.67% 3M change

36.99% 12M change

Total Value Held $561,545

Ingrid Delaet Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 13 2025	SELL Open market or private sale	$171,680 $116.71 p/Share	1,471 Reduced 23.72%	4,730 Common Stock
Feb 13 2025	BUY Exercise of conversion of derivative security	-	2,759 Added 33.47%	5,485 Common Stock
Feb 03 2025	SELL Open market or private sale	$93,007 $149.29 p/Share	623 Reduced 15.33%	3,442 Common Stock
Feb 03 2025	BUY Exercise of conversion of derivative security	-	1,179 Added 22.48%	4,065 Common Stock
Jan 31 2025	SELL Open market or private sale	$64,587 $153.05 p/Share	422 Reduced 12.76%	2,886 Common Stock
Jan 31 2025	BUY Exercise of conversion of derivative security	-	801 Added 19.49%	3,308 Common Stock
Dec 31 2024	SELL Open market or private sale	$37,563 $138.1 p/Share	272 Reduced 9.79%	2,507 Common Stock
Dec 31 2024	BUY Exercise of conversion of derivative security	$21,493 $79.02 p/Share	272 Added 8.92%	2,779 Common Stock
Dec 17 2024	SELL Open market or private sale	$147,285 $135.0 p/Share	1,091 Reduced 30.32%	2,507 Common Stock
Dec 17 2024	BUY Exercise of conversion of derivative security	$86,210 $79.02 p/Share	1,091 Added 23.27%	3,598 Common Stock
Aug 13 2024	SELL Open market or private sale	$1,072,235 $150.11 p/Share	7,143 Reduced 74.02%	2,507 Common Stock
Aug 13 2024	BUY Exercise of conversion of derivative security	$315,011 $103.52 p/Share	3,043 Added 23.97%	9,650 Common Stock
Aug 06 2024	SELL Open market or private sale	$40,322 $147.7 p/Share	273 Reduced 3.97%	6,607 Common Stock
Aug 06 2024	BUY Exercise of conversion of derivative security	$21,572 $79.02 p/Share	273 Added 3.82%	6,880 Common Stock
Jul 16 2024	SELL Open market or private sale	$428,692 $150.05 p/Share	2,857 Reduced 30.19%	6,607 Common Stock
Jul 16 2024	BUY Exercise of conversion of derivative security	$202,588 $103.52 p/Share	1,957 Added 17.76%	9,064 Common Stock
Jul 01 2024	SELL Open market or private sale	$37,565 $138.11 p/Share	272 Reduced 3.5%	7,507 Common Stock
Jul 01 2024	BUY Exercise of conversion of derivative security	$21,493 $79.02 p/Share	272 Added 3.38%	7,779 Common Stock
May 31 2024	SELL Open market or private sale	$37,278 $136.55 p/Share	273 Reduced 3.51%	7,507 Common Stock
May 31 2024	BUY Exercise of conversion of derivative security	$21,572 $79.02 p/Share	273 Added 3.39%	7,780 Common Stock
May 06 2024	SELL Open market or private sale	$38,370 $140.55 p/Share	273 Reduced 3.51%	7,507 Common Stock
May 06 2024	BUY Exercise of conversion of derivative security	$21,572 $79.02 p/Share	273 Added 3.39%	7,780 Common Stock
Apr 01 2024	SELL Open market or private sale	$37,345 $137.3 p/Share	272 Reduced 3.5%	7,507 Common Stock
Apr 01 2024	BUY Exercise of conversion of derivative security	$21,493 $79.02 p/Share	272 Added 3.38%	7,779 Common Stock
Mar 21 2024	SELL Open market or private sale	$725,300 $145.06 p/Share	5,000 Reduced 39.98%	7,507 Common Stock

Ingrid Delaet

Chief Regulatory Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBIX shares.

Notify only if

Value

Insider Trading

Get notified when an Neurocrine Biosciences Inc insider buys or sells NBIX shares.

Notify only if

Operation

Value

Type

News

Receive news related to NEUROCRINE BIOSCIENCES INC

Track Activities on NBIX

Account